BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18781178)

  • 1. p53-independent mechanisms regulate the P2-MDM2 promoter in adult astrocytic tumours.
    Dimitriadi M; Poulogiannis G; Liu L; Bäcklund LM; Pearson DM; Ichimura K; Collins VP
    Br J Cancer; 2008 Oct; 99(7):1144-52. PubMed ID: 18781178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of MDM2 SNP309, transcriptional activity, mRNA expression, and survival in stage I non-small-cell lung cancer patients with wild-type p53 tumors.
    Chien WP; Wong RH; Cheng YW; Chen CY; Lee H
    Ann Surg Oncol; 2010 Apr; 17(4):1194-202. PubMed ID: 19941079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated transcript levels from the MDM2 P1 promoter and low p53 transcript levels are associated with poor prognosis in human pancreatic ductal adenocarcinoma.
    Grochola LF; Taubert H; Greither T; Bhanot U; Udelnow A; Würl P
    Pancreas; 2011 Mar; 40(2):265-70. PubMed ID: 21404460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of a single nucleotide polymorphism of MDM2 in glioblastoma multiforme.
    Khatri RG; Navaratne K; Weil RJ
    J Neurosurg; 2008 Nov; 109(5):842-8. PubMed ID: 18976073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL.
    Dong HJ; Fang C; Fan L; Zhu DX; Wang DM; Zhu HY; Zhuang Y; Miao KR; Liu P; Xu W; Li JY
    Int J Cancer; 2012 May; 130(9):2054-61. PubMed ID: 21647873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common polymorphisms in the MDM2 and TP53 genes and the relationship between TP53 mutations and patient outcomes in glioblastomas.
    Zawlik I; Kita D; Vaccarella S; Mittelbronn M; Franceschi S; Ohgaki H
    Brain Pathol; 2009 Apr; 19(2):188-94. PubMed ID: 18462472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
    Phelps M; Darley M; Primrose JN; Blaydes JP
    Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer.
    Ralhan R; Sandhya A; Meera M; Bohdan W; Nootan SK
    Am J Pathol; 2000 Aug; 157(2):587-96. PubMed ID: 10934161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of MDM2 SNP309 alone or in combination with the TP53 R72P polymorphism in oligodendroglial tumors.
    Idbaih A; Boisselier B; Marie Y; Sanson M; El Hallani S; Crinière E; Fourtassi M; Paris S; Carpentier C; Rousseau A; Mokhtari K; Combadière C; Laigle-Donadey F; Hoang-Xuan K; Delattre JY
    Brain Res; 2008 Mar; 1198():16-20. PubMed ID: 18262501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HDM2 transcript levels with age of onset and prognosis in soft tissue sarcomas.
    Taubert H; Bartel F; Greither T; Bache M; Kappler M; Köhler T; Böhnke A; Lautenschläger C; Schmidt H; Holzhausen HJ; Hauptmann S; Würl P
    Mol Cancer Res; 2008 Oct; 6(10):1575-81. PubMed ID: 18922973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of functional DNA variants in the constitutive promoter region of MDM2.
    Lalonde ME; Ouimet M; Larivière M; Kritikou EA; Sinnett D
    Hum Genomics; 2012 Sep; 6(1):15. PubMed ID: 23244604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
    Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G
    Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uniform MDM2 overexpression in a panel of glioblastoma multiforme cell lines with divergent EGFR and p53 expression status.
    Halatsch ME; Schmidt U; Unterberg A; Vougioukas VI
    Anticancer Res; 2006; 26(6B):4191-4. PubMed ID: 17201132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients.
    Schmidt MK; Tommiska J; Broeks A; van Leeuwen FE; Van't Veer LJ; Pharoah PD; Easton DF; Shah M; Humphreys M; Dörk T; Reincke SA; Fagerholm R; Blomqvist C; Nevanlinna H
    Breast Cancer Res; 2009; 11(6):R89. PubMed ID: 20021639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of MDM2 and p53 polymorphisms with the advancement of cervical carcinoma.
    Singhal P; Hussain S; Thakur N; Batra S; Salhan S; Bhambani S; Bharadwaj M
    DNA Cell Biol; 2013 Jan; 32(1):19-27. PubMed ID: 23210739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.
    Gryshchenko I; Hofbauer S; Stoecher M; Daniel PT; Steurer M; Gaiger A; Eigenberger K; Greil R; Tinhofer I
    J Clin Oncol; 2008 May; 26(14):2252-7. PubMed ID: 18467716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential.
    Barak Y; Gottlieb E; Juven-Gershon T; Oren M
    Genes Dev; 1994 Aug; 8(15):1739-49. PubMed ID: 7958853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death.
    Rosso M; Polotskaia A; Bargonetti J
    Oncotarget; 2015 Oct; 6(33):34573-91. PubMed ID: 26416444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D directly regulates Mdm2 gene expression in osteoblasts.
    Chen H; Reed G; Guardia J; Lakhan S; Couture O; Hays E; Chandar N
    Biochem Biophys Res Commun; 2013 Jan; 430(1):370-4. PubMed ID: 23149414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association of MDM2 SNP309 with risk of glioblastoma and prognosis.
    El Hallani S; Marie Y; Idbaih A; Rodero M; Boisselier B; Laigle-Donadey F; Ducray F; Delattre JY; Sanson M
    J Neurooncol; 2007 Dec; 85(3):241-4. PubMed ID: 17568997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.